Hetal Doshi

Director of Portfolio & Program Management | Strategy Execution | Organization Change Strategy | Alliance Management | Mentor

Role
Director, Global Portfolio & Program Management Drug Development at Daiichi Sankyo US
Location
Dallas-Fort Worth, TX, US
LinkedIn followers
500 followers

About Hetal Doshi

With over 15+ years of experience in the biopharmaceutical industry, I am a Director of Business Operations at AbbVie, a global leader in developing innovative therapies for patients with serious diseases. I hold an MBA from Northwestern University and a PMP certification, reflecting my strong business acumen and project management skills.My core competencies include portfolio and program management, product management, process improvement, change management, communication, vendor management, and alliance management. I have led and executed complex, cross-functional initiatives across R&D, Pharmacovigilance & Patient Safety, Regulatory, Healthcare & Digital Technology, Patient Experience, Integration, and Mergers & Acquisitions. I have delivered on time and on budget outcomes, brought five products to market, increased process efficiency by 15% in safety operations, and facilitated monthly governance meetings with senior leadership. I have also established PMO offices and developed standardized PMO processes, gaining alignment and agreement from stakeholders and sponsors on goals and objectives, and developing compelling value propositions and business cases. I have extensive experience working with pharmaceutical, biotech, academic institutions, and CROs, and I am passionate about improving patient care and outcomes through innovation and collaboration.As a culture champion and a mentor, I value diversity, inclusion, and learning. I am always looking for new opportunities to grow and contribute to the success of AbbVie and the industry. I am driven by the mission of making a remarkable impact on people\'s lives.

Experience

  1. Director, Global Portfolio & Program Management Drug Development

    Daiichi Sankyo US

    Jan 2024 — Present

    Strategic Leadership: Independently lead strategy development on Global Project Teams (GPT) for drug development projects across all phases of development, ensuring alignment with integrated product development plans in Oncology TA.Team Development: Develop high-performing teams, partnering with Global Team Leaders and Clinical Team Leaders to drive the execution of clinical and product development strategies.Resource Management: Oversee the planning and allocation of program/project resources, working closely with finance and functional team members to secure adequate resourcing and budget alignment.Project Planning and Risk Management: Maintain global integrated project plans, timelines, risk management plans, and communication plans. Generate strategic governance materials with scenario planning to solve complex problems and manage stakeholder situations effectively.Annual Portfolio Prioritization: Lead the annual portfolio prioritization process, ensuring that resources are allocated to high-impact projects and that strategic goals are met. Collaborate with senior management to align project priorities with overall company objectives.

Education

  • Northwestern University - Kellogg School of Management

    Executive MBA

    2019 — 2022

  • East Carolina University - College of Business

    MBA

    2002 — 2003

  • The Maharaja Sayajirao University of Baroda

    Bachelor’s Degree

    1997 — 2000

  • Convent of Jesus & Mary

    High School Diploma

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Hetal Doshi — Director, Global Portfolio & Program Management Drug Development at Daiichi Sankyo US in Dallas-Fort Worth, TX, US | Unifers